4//SEC Filing
Eltoukhy Helmy 4
Accession 0001752968-26-000002
CIK 0001576280other
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 5:55 PM ET
Size
13.6 KB
Accession
0001752968-26-000002
Insider Transaction Report
Form 4
Eltoukhy Helmy
DirectorCo-Chief Executive Officer
Transactions
- Exercise/Conversion
Common Stock
2025-12-31+4,815→ 2,051,958 total - Tax Payment
Common Stock
2025-12-31$102.14/sh−2,441$249,324→ 2,049,517 total - Exercise/Conversion
Common Stock
2026-01-01+23,997→ 2,073,514 total - Tax Payment
Common Stock
2026-01-01$102.14/sh−10,788$1,101,886→ 2,062,726 total - Exercise/Conversion
Restricted Stock Units
2025-12-31−4,815→ 0 totalExercise: $0.00→ Common Stock (4,815 underlying) - Exercise/Conversion
Restricted Stock Units
2026-01-01−23,997→ 95,989 totalExercise: $0.00→ Common Stock (23,997 underlying)
Footnotes (4)
- [F1]These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability.
- [F2]This represents a restricted stock unit award granted on March 12, 2025 that vests in four equal installments on the last day of each calendar quarter, March 31, 2025, June 30, 2025, September 30, 2025, and December 31, 2025.
- [F3]Not applicable for Restricted Stock Units.
- [F4]This represents a restricted stock unit award granted on March 18, 2024 that vests over a three-year period. 33% of the shares subject to such award vested on January 1, 2025 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter.
Documents
Issuer
Guardant Health, Inc.
CIK 0001576280
Entity typeother
Related Parties
1- filerCIK 0001752968
Filing Metadata
- Form type
- 4
- Filed
- Jan 4, 7:00 PM ET
- Accepted
- Jan 5, 5:55 PM ET
- Size
- 13.6 KB